Myo-Inositol
Mechanism of Action +
### Introduction to Inositol Biochemistry Myo-inositol (cis-1,2,3,5-trans-4,6-cyclohexanehexol) is the most abundant of the nine distinct stereoisomers of inositol, a six-carbon sugar alcohol. While historically classified as Vitamin B8, it is not a true vitamin because the human body can synthesize it endogenously from glucose-6-phosphate. Endogenous synthesis primarily occurs in the kidneys, producing approximately 4 grams daily, while a typical Western diet provides an additional 1 gram per day from sources like fruits, beans, grains, and nuts. At the cellular level, myo-inositol is a fundamental component of structural lipids (phosphatidylinositols) and serves as a precursor for a vast array of secondary messengers in eukaryotic cells.
### Insulin Signal Transduction and Phosphoinositides The primary mechanism by which myo-inositol exerts its clinical benefits—particularly in metabolic syndrome and Polycystic Ovary Syndrome (PCOS)—is through the amplification of insulin signaling. When insulin binds to its extracellular receptor, it triggers the autophosphorylation of intracellular tyrosine residues, leading to the activation of insulin receptor substrates (IRS). This activation stimulates phosphoinositide 3-kinase (PI3K), which phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3).
PIP3 acts as a docking site for phosphoinositide-dependent kinase-1 (PDK1) and Akt (Protein Kinase B). The activation of Akt is the critical node that promotes the translocation of GLUT4 glucose transporters to the cell membrane, facilitating cellular glucose uptake. Furthermore, myo-inositol is incorporated into inositolphosphoglycans (IPGs), which are cleaved and released into the cytoplasm upon insulin receptor activation. These IPGs act as insulin mimetics, directly activating enzymes involved in oxidative and non-oxidative glucose metabolism, such as pyruvate dehydrogenase and glycogen synthase. By increasing the availability of these secondary messengers, myo-inositol supplementation effectively reduces insulin resistance, a core pathology in metabolic syndrome and PCOS.
### Ovarian Function and Steroidogenesis In the context of female reproductive health, the ratio of myo-inositol (MI) to D-chiro-inositol (DCI) is tightly regulated by an insulin-dependent epimerase enzyme. In healthy tissues, the physiological ratio of MI to DCI is approximately 40:1 in plasma. Myo-inositol is crucial for the action of Follicle-Stimulating Hormone (FSH) in the ovaries. FSH signaling relies on myo-inositol-dependent pathways to promote follicular maturation and estrogen synthesis.
In women with PCOS, systemic insulin resistance leads to compensatory hyperinsulinemia. Paradoxically, while muscle and liver tissues remain insulin resistant, the ovaries often retain insulin sensitivity. The excess insulin overstimulates the epimerase enzyme in the ovaries, leading to an accelerated conversion of myo-inositol into D-chiro-inositol. This creates a localized myo-inositol deficiency in the follicular fluid, impairing FSH signaling and arresting follicular development, while the excess D-chiro-inositol promotes androgen synthesis (hyperandrogenism). Supplementing with myo-inositol restores the intracellular pool, re-establishing normal FSH signaling, promoting ovulation, and reducing excess testosterone production.
### Neurotransmitter Modulation and CNS Effects Beyond metabolic and reproductive health, myo-inositol plays a role in central nervous system (CNS) function. It is highly concentrated in brain tissue, where it is required for the phosphoinositide cycle that mediates signaling for several neurotransmitter receptors, including serotonin (5-HT2), dopamine, and norepinephrine. Upon receptor activation, phospholipase C (PLC) cleaves PIP2 into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 binds to receptors on the endoplasmic reticulum, triggering the release of intracellular calcium, which is essential for neurotransmitter exocytosis and synaptic plasticity.
Clinical evidence from Examine.com indicates that myo-inositol supplementation can reduce the frequency and severity of panic attacks (Grade B evidence), likely by enhancing the sensitivity of serotonin receptors and stabilizing neuronal membrane potentials. However, it appears ineffective for severe psychiatric conditions like bipolar disorder or schizophrenia-related depression (Grade D evidence).
### Pharmacokinetics and Bioavailability Orally administered myo-inositol is rapidly absorbed in the gastrointestinal tract via sodium-dependent inositol co-transporters (SMIT1 and SMIT2). Peak plasma concentrations are typically reached within 2 to 4 hours post-ingestion. The cellular uptake of myo-inositol is highly competitive with glucose, as both molecules share similar transport mechanisms. Consequently, chronic hyperglycemia (as seen in uncontrolled diabetes or severe metabolic syndrome) can competitively inhibit myo-inositol uptake, leading to intracellular depletion and exacerbating insulin resistance. This underscores the therapeutic rationale for high-dose myo-inositol supplementation (2,000 to 4,000 mg daily) to overcome competitive inhibition and restore intracellular concentrations.
What does myo-inositol supplement do? +
Who should not take inositol? +
Can I take inositol and NAC together? +
Can inositol help lower A1c? +
What should not be taken with inositol? +
Can inositol help ADHD? +
Can inositol lower cortisol? +
Is inositol a vitamin? +
How long does it take for inositol to work? +
What is the best ratio of myo-inositol to d-chiro-inositol? +
Does inositol help with weight loss? +
Can men take myo-inositol? +
Does inositol cause side effects? +
Can I get inositol from food? +
Does inositol help with anxiety and panic attacks? +
Is inositol safe during pregnancy? +
Does inositol improve sleep? +
Can inositol treat depression? +
Everything About Myo-Inositol Article
## Introduction to Myo-Inositol Myo-inositol is a naturally occurring carbocyclic sugar that is fundamental to human cellular function. Often incorrectly referred to as Vitamin B8, myo-inositol is not a true vitamin because the human body can synthesize it from glucose. It is found abundantly in foods like fruits, beans, grains, and nuts. However, in the realm of clinical nutrition and supplementation, myo-inositol has emerged as a powerhouse ingredient for managing metabolic and reproductive health.
At its core, myo-inositol acts as a secondary messenger. When hormones like insulin or neurotransmitters like serotonin bind to the outside of a cell, myo-inositol is responsible for transmitting that signal to the inside of the cell, ensuring the body responds appropriately. This mechanism makes it incredibly valuable for conditions characterized by cellular resistance to hormones, most notably Polycystic Ovary Syndrome (PCOS) and metabolic syndrome.
## The Science Behind the Benefits The clinical efficacy of myo-inositol is backed by a substantial body of research. According to Examine.com, the database incorporates findings from 8 meta-analyses involving 5,645 participants across 38 trials. The evidence is particularly strong for female reproductive health, but its benefits extend into metabolic and mental health as well.
### Polycystic Ovary Syndrome (PCOS) and Fertility The most well-documented use of myo-inositol is in the management of PCOS, carrying a Grade A evidence rating from Examine.com based on 10 studies and over 700 participants. PCOS is fundamentally driven by insulin resistance, which leads to compensatory hyperinsulinemia. This excess insulin overstimulates the ovaries, causing them to produce excess androgens (like testosterone) and arresting the development of ovarian follicles, leading to irregular periods and infertility.
Myo-inositol works by restoring insulin sensitivity at the cellular level. Furthermore, it is a crucial component of the signaling pathway for Follicle-Stimulating Hormone (FSH). By replenishing myo-inositol levels in the follicular fluid, supplementation helps restore normal ovulation, improves egg quality, and significantly increases fertility rates. Many premium supplements, such as those from Fairhaven Health and Intimate Rose, combine myo-inositol with D-chiro-inositol in a 40:1 ratio, which mimics the body's natural physiological balance and has been shown to be the most effective protocol for PCOS.
### Metabolic Health and Insulin Resistance Beyond PCOS, myo-inositol is a potent tool for managing metabolic syndrome. The Cleveland Clinic notes that metabolic syndrome is a cluster of conditions—including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels—that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes.
Myo-inositol improves the body's ability to process insulin. When insulin binds to its receptor, myo-inositol-derived molecules (inositolphosphoglycans) are released into the cell, acting as "insulin mimetics" that directly stimulate the enzymes responsible for burning glucose for energy. WebMD highlights that taking inositol by mouth, especially alongside alpha-lipoic acid, seems to improve insulin resistance, lower triglyceride levels, and improve blood pressure in people with metabolic syndrome.
### Pregnancy and Gestational Diabetes During pregnancy, the body naturally becomes more insulin resistant to ensure adequate nutrient delivery to the growing fetus. However, in some women, this progresses to gestational diabetes. Clinical evidence shows that supplementing with myo-inositol during pregnancy can significantly reduce the risk of developing gestational diabetes. Furthermore, WebMD notes that taking inositol with folic acid during pregnancy seems to lower the risk of preterm birth in high-risk populations.
### Mental Health: Panic Attacks and Anxiety Because myo-inositol is highly concentrated in the brain and is involved in the signaling pathways for serotonin and dopamine, it has been studied for various psychiatric conditions. Examine.com awards a Grade B rating for its ability to reduce the frequency and severity of panic attacks. While it is not a rapid-acting anxiolytic, chronic supplementation helps stabilize neuronal signaling.
It is important to note the limitations of myo-inositol in mental health. While it helps with panic disorder, Examine.com gives it a Grade D (ineffective) rating for treating bipolar disorder, schizophrenia-related depression, and PMS/PMDD-related depression. WebMD corroborates this, stating that taking inositol by mouth does not seem to improve general symptoms of depression.
## Dosing Strategies and Best Practices The clinical standard for myo-inositol supplementation ranges from 1,000 to 4,000 mg per day. For the management of PCOS and metabolic syndrome, the most common and effective dose is 2,000 mg taken twice daily (totaling 4,000 mg).
When selecting a supplement, the form matters. Myo-inositol is the most abundant and researched form. However, for PCOS, looking for a product that includes D-chiro-inositol in a 40:1 ratio (e.g., 2,000 mg of myo-inositol to 50 mg of D-chiro-inositol) is considered the gold standard.
Myo-inositol is generally very well tolerated. Because it is a naturally occurring sugar alcohol, it does not cause the gastrointestinal distress associated with some other supplements, though very high doses (above 12 grams) may cause mild stomach upset. It can be taken with or without food, though taking it alongside meals may help blunt the post-meal blood sugar spike due to its insulin-sensitizing effects.